Abstract. RNA polymerase I preparations purified from a rat hepatoma contained DNA topoisomerase activity. The DNA topoisomerase associated with the polymerase had an Mr of 110000, required Mg 2+ but not ATP, and was recognized by anti-topoisomerase I antibodies. When added to RNA polymerase I preparations containing topoisomerase activity, anti-topoisomerase I antibodies were able to inhibit the DNA relaxing activity of the preparation as well as RNA synthesis in vitro. RNA polymerase II prepared by analogous procedures did not contain topoisomerase activity and was not recognized by the antibodies. The topoisomerase I: polymerase I complex was reversibly dissociated by column chromatography on Sephacryl $200 in the presence of 0.25 M (NH4)2SO,~. Topoisomerase I was immunolocalized in the transcriptionally active ribosomal gene complex containing RNA polymerase I in situ. These data indicate that topoisomerase I arid RNA polymerase I are tightly complexed both in vivo and in vitro, and suggest a role for DNA topoisomerase I in the transcription of ribosomal genes.
Introduction
The DNA topoisomerases are a group of enzymes with the ability to interconvert topological isomers of DNA by breaking and resealing phosphodiester bonds (for recent reviews see Liu 1984; Vosberg 1985; Wang 1985) . Type I topoisomerase, first described in prokaryotes by Wang (1971) and in eukaryotes by Champoux and Dulbecco (1972) and later characterized by Keller (1975 a, b) , change the linking number in steps of one. Although their biological function is not completely defined, this class of topoisomerase has been implicated in transcriptional (Akrigg and Cook 1980; Dynan and Burgess 1981 ; Sternglanz et al. 1981; Weisbrod 1982; Fleischmann et al. 1984; Gilmour et al. 1986; Shastry 1986 ) as well as in recombinational and replicational (Kikuchi and Nash 1979; Sternglanz et al. 1981 ; also see Gellert 1981 ; Bullock et al. 1985; Zeng et al. 1985) events. In higher eukaryotes topoisomerase I is enriched in the nucleolus (Fleischmann et al. 1984; Muller et al. 1985) and may play a role in transcription of supercoiled rDNA in vitro (Garg et al. 1987) . Studies in Tetrahymena indicate that the ribosomal DNA-associated enzyme Offprint requests to: K.M. Rose is located at DNase I hypersensitive sites in the nontranscribed rDNA spacer region (Bonven et al. 1985) . In vitro the activity of topoisomerase I is inhibited by polyADPribosylation (Jonstra-Bilen et al. 1983; Ferro and 0livers 1984) . Conversely, the activity is stimulated when the enzyme is phosphorylated by casein kinase II (Durban et al. 1985) .
The DNA-dependent enzyme, RNA polymerase I, is responsible for the transcription of ribosomal genes (for reviews see Roeder 1976; Jacob and Rose 1978) . This polymerase is associated with actively transcribed nucleolar genes and is localized in the fibrillar center of that organelle . Further, RNA polymerase I is phosphorylated by a type II casein kinase, nuclear protein kinase NII (Rose et al. 1981 a, b) , and this modification enhances transcription (Duceman etal. 1981; Rose etal. 1983) . Taken together with the observations concerning topoisomerase I these data suggest an intriguing relationship between topoisomerase I and RNA polymerase I. We now wish to report that a topoisomerase I activity is reversibly associated with highly purified preparations of RNA polymerase I and that inhibition of the topoisomerase activity of the complex inhibits transcription. Further, topoisomerase I is shown to be present in the active ribosomal gene transcription complex in situ.
Materials and methods
Enzyme purification. RNA polymerase I was purified by sequential column chromatography on DEAE-Sephadex, Affi-gel Blue and heparin-Sepharose followed by sedimentation on sucrose gradients essentially as described previously (Rose et al. 1981a ) except that 25% glycerol was included and 0.2-0.25 M (NHg)zSO4 sometimes replaced KC1 in the sucrose gradient buffer (sedimentation time was increased to 16 h to accommodate the increased viscosity of the gradient). Purified RNA polymerase I had a specific activity of 100 nmol UMP incorporated in 30 min per milligram protein measured under optimal conditions (Rose et al. 1976) . Topoisomerase I was obtained from the sucrose gradient of the polymerase preparation. Fractions that sedimented from approximately 7-10 S were pooled and purified in a manner analogous to that described for protein kinase NII . The final step in the purification, ATP-Sepharose chromatography, separated the remaining protein kinase from the topoisomerase, which eluted in the flow-through fractions. Purified topoisomerase had a specific activity of 150 000 units per milligram protein.
One unit represents the capacity to relax l gg supercoiled DNA in 30 rain at 37 ~ C.
Topoisomerase assay. Reactions (26 pl final volume) contained 5 mM MgCI2, 0.1 mM EDTA, 25 mM KC1, enzyme diluted in buffer containing final concentrations of 0.2 mM dithiothreitol, 20 mM Tris-C1, pH 7.9, 20% glycerol, and 160 ng pBR322 DNA (obtained from BRL, approximately 75% in the supercoiled form). Following incubation for 45 rain at 37 ~ C, reactions were terminated by addition of 1 ~tl of solution containing 1% sodium dodecyl sulfate, 0.25% xylene cyanol, 0.25% bromophenol blue and 30% glycerol. Samples were loaded onto a 0.5% agarose gel and electrophoresis was carried out at 30 V for 16 h at 23~ in buffer containing 40 mM Tris-acetate, pH 8, 1 mM EDTA. Following electrophoresis, the gels were immersed in ethidium bromide solution (40 ng/ml) for 30 min and destained in H20 for 1-2 h. DNA was visualized with a Photodyne 3-3000 UV transilluminator. In those instances in which electrophoresis was conducted in the presence of ethidium bromide (relaxation assay), the intercalating agent was included in the running buffer at a concentration of 20 ng/ml. To enhance visualization, these gels were also immersed in ethidium bromide following electrophoresis. Data were quantitated by laser beam densitometry.
RNA polymerase assay and immunoblotting. RNA synthesis was measured as described previously (Szopa and Rose 1986) . Immunoblotting was also conducted as described therein.
Anti-topoisomerase antibodies. Monoclonal antibodies against human topoisomerase I were prepared by a modification of the technique described by K6hler and Milstein (1975) . A complete description of the protocol will be presented elsewhere (F.S. Han and Y-C. Cheng, in preparation). Antibodies were purified by DEAE-Affi gel Blue or protein A-Sepharose chromatography and dialyzed into buffer containing 0.1 M Tris-C1, pH 7.4. Polyclonal antibodies were prepared by immunization of rabbits with topoisomerase I purified from calf thymus. Immunoglobulins were purified by protein A-Sepharose chromatography. Monospecific antibodies were prepared by elution with 10 mM Hepes, pH 2.8 (Fleischmann et al. 1984 ) from immunoblots of topoisomerase I.
Immunofluoreseenee microscopy. An established rat cell line (RV-SMC) was prepared for immunofluorescence microscopy as described . The cells were incubated with affinity purified rabbit antibodies to topoisomerase I (15 pg/ml in PBS for 20 min at room temperature), washed several times in PBS followed by incubation with FITC-labeled anti-rabbit IgG diluted 1:20 (Dianova, Hamburg, FRG). In some experiments cells were exposed for 6 h to 50 gg/ml 5,6-dichloro-D-ribofuranosylbenzimidazole (DRB) (Seheer et al. 1984) prior to immunostaining.
Results
First we evaluated whether topoisomerase activity was present in purified RNA polymerase preparations. As shown in Figure l , a highly purified polymerase I fraction isolated from sucrose gradients performed in 0.3 M KC1 was able to change the linking number of superhelical (form I) DNA. This activity was dependent on both enzyme concentration To compare this activity with that of a pure topoisomerase, we isolated a topoisomerase independent of RNA polymerase. Preliminary experiments indicated that the bulk of the ATP-independent topoisomerase activity in the nuclear extracts used for purification of RNA polymerase I copurifled with this polymerase. The last step in polymerase I purification is sedimentation through sucrose gradients in the presence of 0.3 M KC1 (Rose et al. 1981a) or 0.25 M (NH4)zSO4 (for optimal release of associated polypeptides). Because of the large size of the polymerase (>15S) and the presence of the salt this step is efficient in the removal of enzyme-bound polypeptides. Thus, the upper fractions of the gradient can be used for the further purification of proteins that have an affinity for the enzyme but are released by the high salt and/or by the shear forces of the gradient as well as for purification of enzyme subunits that have "disassembled" during the gradient stage. Topoisomerase I was purified from the fractions of the gradient containing both protein kinase NII (approximately 6-7S; Rose et al. 1981 a) and topoisomerase activities. The topoisomerase copurified with the kinase through the caseinand phosvitin-Sepharose columns but, unlike the kinase, was not retained on the ATP-Sepharose columns. The purified topoisomerase activity was dependent on both time and enzyme concentration (not shown) and required Mg + +, but not ATP (Fig. 1, lanes 7-9) .
The purified topoisomerase appeared to be a single polypeptide with an Mr of 110000 as estimated by analysis on polyacrylamide gels in the presence of sodium dodecyl sulphate (Fig. 2, lane 1) . The size of this topoisomerase, coupled with its enzymatic properties suggested that it was a type I topoisomerase. To confirm this, the purified enzyme was analyzed by immunoblotting using monoclonal Topoisomerase I and RNA polymerase I were purified as described in Material and methods and subjected to linear polyacrylamide gradient (4.5% 12.5%) gel electrophoresis essentially as described by Laemmli (1970) . Lane 1, topoisomerase I, 1 lag, stained with Coomassie Blue; lane 2, RNA polymerase I, 70 ng, stained with silver. Proteins from analogous gels were transferred to nitrocellulose and reacted with anti-topoisomerase antibodies (lanes 3 and 4) as described in Materials and methods. Lane 3, topoisomerase I (1 lag); lane 4, RNA polymerase I (10 lag) antibodies against topoisomerase I. As shown in Figure 2 , lane 3, the antibodies recognized the 110000 Mr polypeptide. Two smaller polypeptides, not visible on the proteinstained gel, were also detected on the immunoblots; presumably these were cleavage products since they are not observed in freshly prepared enzyme preparations (see also Schmitt et al. 1984; Guldner et al. 1986; Shero et al. 1986 ). To evaluate whether RNA polymerase I preparations contained a similar topoisomerase they were analyzed in an analogous manner. As indicated in Figure 2 , lane 2, purified RNA polymerase I purified on sucrose gradients containing 0.3 M KC1 contains several polypeptides; most evident are those of Mr 190000 and 110000. The minor bands shown in this gel are degradation products of the M~ 190000 polypeptide. When larger quantities of the enzyme are applied to the gel, the smaller polypeptides, (Mr 65000, 42000, 25000) associated with the polymerase, can be visualized. As shown in Figure 2 , lane 4, the monoclonal antibodies against topoisomerase I reacted with an Mr 110000 polypeptide of the RNA polymerase I preparation. As an aside it should be mentioned that RNA polymerase II purified by methods analogous to polymerase I neither contained topoisomerase activity nor reacted with the anti-topoisomerase antibodies on immunoblots (not shown). A recent report based on in vivo crosslinking has also provided evidenCe that RNA polymerase II and topoisomerase I are not tightly associated but interact independently with transcribed sequences (Gilmour et al. 1986 ).
To evaluate whether the association between RNA polymerase I and topoisomerase had any functional significance, we examined RNA synthesis in the presence of the anti-topoisomerase antibodies. We chose a range of antibody concentrations that were capable of preventing the conversion of negatively super-coiled DNA to the relaxed form. As can be seen in Figure 3 , lanes 3-7, in the presence of the antibodies, the topoisomerase activity in the polymerase preparation was able to open the negatively super-coiled DNA, but not to reseal it. It should be noted that inhibition of an equivalent amount of relaxing activity of the purified topoisomerase (separated from polymerase) required less antibody (Fig. 3, lane 14) . Whether the need to use more antibodies to inhibit the polymerase I-associated enzyme reflected the presence of inactive topoisomerase molecules or restricted access of the antibodies to their binding sites as a result of association of the topoisomerase with the polymerase is not known. In a separate experiment we examined the effect of the topoisomerase antibodies on RNA synthesis. As shown in Figure 4 , RNA polymerase I activity was inhibited by the topoisomerase antibodies. Similar concentrations of immunoglobulins purified from normal mouse serum had no effect on RNA synthesis. Using the same anti-topoisomerase antibody preparation, inhibition of the purified topoisomerase was also observed. As had been observed in Figure 3 , it required less antibody to inhibit the isolated topoisomerase activity. To evaluate whether the topoisomerase was tightly bound to the polymerase, we immobilized anti-topoisomerase antibodies on DEAE Affi-gel Blue or protein A-Sepharose beads, and added them to RNA polymerase I. In two different experiments, beads containing the anti-topoisomerase I antibodies removed 45%-47% of the polymerase I activity from solution, whereas beads containing control immunoglobulins removed less than 5% of the enzyme activity. To determine whether the antibody-induced inhibition of RNA polymerase I was nonspecific, we added topoisomerase I to RNA polymerase II and then added the anti-topoisomerase antibodies; no inhibition wasobserved in this case.
The foregoing suggested that polymerase I and topoisomerase I formed a complex in vitro. To ascertain whether this was a reversible complex we tried to dissociate the enzymes by gel filtration chromatography under various salt conditions. Initial experiments suggested that the Mr 110000 topoisomerase coeluted with the Mr 500 000-600000 polymerase at NaC1 or NH4CI concentrations up to 0.8 M. However, when 0.25 M (NHr was used as the salt the enzymes could be dissociated into separately eluting entities (Fig. 5A) . The polymerase I: topoisomerase I complex was completely reversible and the enzymes in the reconstituted complex coeluted at 20 mM (NH4)2SO 4 (Fig. 5 B) . For comparison, the elution profiles of the dissociated enzymes individually subjected to chromatography at 20 mM (NH4)2SO4 are shown in Figure 5 C (topoisomerase) and D (polymerase). Note that at 20 mM (NH4)2SO4, the topoisomerase alone does not aggregate and elutes at the same elution volume as under the 0.25 M (NH4)2SO4 conditions.
Using immunocytochemical methods, we have previously denionstrated the presence of RNA polymerase I Fig. 3 . Inhibition of topoisomerase activity by anti-topoisomerase antibodies. RNA polymerase I (260 ng) or topoisomerase I (500 pg) were preincubated with anti-topoisomerase antibodies for 20 rain at 30 ~ C in buffer containing 40 mM Tris-C1, pH 7.5, 5 mM MgC12, 0.1 mM EDTA. DNA was then added and the reactions incubated for 45 min at 37 ~ C. Reactions were terminated by addition of sodium dodecyl sulfate (0.5% final concentration). Following incubation in the presence of 2 x 10 -3 units of proteinase K for 15 min at 37 ~ C, reaction products were processed on 0.5% agarose gels containing 0.02 lag/ml ethidium bromide as described in Materials Fig. 4 . Effect of anti-topoisomerase antibodies on RNA synthesis. RNA polymerase I was preincubated for 5 rain at 30 ~ C with antitopoisomerase antibodies as indicated. RNA synthesis was then measured by incubation with DNA and appropriate cofactors as described (Szopa and Rose 1986 ) (e). In a parallel experiment, the antibodies were preincubated with topoisomerase I purified from the hepatoma and topoisomerase activity measured, and conversion of form I to form II DNA quantitated by laser beam densitometry (o). Addition of 15-40 lag of normal mouse immunoglobulins purified in an analogous manner to the anti-topoisomerase antibodies had no effect on either RNA synthesis or topoisomerase activity in the active ribosomal gene transcription complex . To investigate whether topoisomerase I is associated with ribosomal genes in situ we examined the localization of topoisomerase I in an established rat cell line. As shown in Figure 6A , B, affinity purified rabbit polyclonal antibodies raised against topoisomerase I stained the nucleoli of these cells very strongly. In addition, the whole nucleoplasm was stained in a finely punctate pattern. In cells treated with DRB, the nucleolar architecture is disrupted (Fig. 6 C) and the RNA-containing chromatin extended . In spite of this,
70 B ribosomal R N A synthesis proceeds at approximately 80% of the normal rate and the actively transcribed genes can be visualized as a beaded structure using anti-RNA polym e r a s e I antibodies and indirect immunofluorescence . Thus treatment of cells with DRB allows precise localization of ribosomal gene transcription units at the level of light microscopy. Therefore we exam- . Cells were fixed and incubated with affinity purified monospecific anti-topoisomerase I antibodies raised in rabbit against enzyme purified from calf thymus and processed as described in . A, C Phase contrast photomicrographs. B, D, Fluorescence photomicrographs. Inset in D, DRB-treated cells incubated with anti-RNA polymerase I antibodies ined the immunofluorescent pattern of topoisomerase I in cells treated with DRB. As shown in Figure 6 D, the topoisomerase I appears as a series of tandemly arrayed dots, indistinguishable from the pattern obtained using anti-RNA potymerase I antibodies which is shown in the inset for comparison. It should be noted that the antibodies against RNA polymerase I react predominantly with the Mr 190000 polypeptide of the polymerase and that monoclonal antibodies against the Mr 190 000 subunit display an analogous pattern to those of the polyclonal antibodies. Other experiments using the anti-topoisomerase I antibodies indicate that the enzyme can be located in the "caps" of segregated nucleoli of actinomycin D treated cells, in the fibrillar centers of nucleoli of tissue prepared for electron microscopy and at the nucleolar organizer regions of metaphase chromosomes (not shown; see also Guldner et al. 1986 ). In no case can we distinguish the nucIeolar pattern from that using anti-RNA polymerase I antibodies. It should be pointed out, however, that in contrast to the strict nucleolar location of RNA polymerase I, topoisomerase I is present both in the nucleolus and the nucleoplasm. As judged from immunofluorescence microscopy, the relative proportion of nucleolar and extranucleolar topoisomerase I seems to be quite variable in different cell types examined.
Discussion
Our data indicate that topoisomerase I can copurify with RNA polymerase I through a variety of ion exchange and affinity chromatography steps as well as sucrose gradient centrifugation or gel fltration steps which contain less than 0.25 M (NH~)2SO4. That the association of the enzymes represents a true complex rather than simple copurification of the two enzymes is demonstrated by their ability to be reassociated following disassociation and separation. Further, the complex of the two enzymes in vitro is sufficiently strong that anti-topoisomerase antibodies bound to the topoisomerase component of the complex can prevent transcription or remove polymerase from solution. It should be noted that although the topoisomerase has an Mr similar to one of the polymerase polypeptides, the topoisomerase does not significantly contribute to the mass of that polymerase polypeptide (less than 25%) and, indeed, polymeraseI purified under stringent conditions still has a Mr ll0000 polypeptide and no topoisomerase activity. Thus topoisomerase should be viewed as a polymerasebinding enzyme rather than as a subunit. This idea is further strengthened by the fact that, at least on calf thymus DNA, topoisomerase activity is not required for trariscription.
The close association between topoisomerase and RNA polymerase I in vitro suggests a role for the topoisomerase in ribosomal gene transcription in vivo. This hypothesis is strongly supported by our observation that these two molecules can be immunocytochemically localized on the same structure in situ. In particular the colocalization of the two enzymes on the DRB-extended nucleolar chromatin provides direct evidence that the topoisomerase is found at the site of ribosomal RNA synthesis. While this manuscript was under review, Zhang et al. (1988) published data implicating a role for topoisomerase I in ribosomal gene transcription in vivo. Taken together with the present study, it seems highly likely that the action of this topoisomerase is required for proper synthesis of rRNA.
